| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0045 | 0.9 |